Citadel Advisors - AGILE THERAPEUTICS INC ownership

AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 33 filers reported holding AGILE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$21,000
-86.5%
102,847
-67.4%
0.00%
Q4 2021$155,000
-54.3%
315,578
-10.3%
0.00%
Q3 2021$339,000
-56.4%
351,983
-39.8%
0.00%
Q2 2021$778,000
-27.2%
584,692
+13.9%
0.00%
Q1 2021$1,068,000
+59.4%
513,437
+120.1%
0.00%
Q4 2020$670,000
+10.0%
233,294
+16.7%
0.00%
Q3 2020$609,000
-19.4%
199,900
-26.4%
0.00%
Q2 2020$756,000
+121.7%
271,776
+47.9%
0.00%
Q1 2020$341,000
+296.5%
183,810
+432.8%
0.00%
Q4 2019$86,000
+258.3%
34,500
-46.5%
0.00%
Q3 2018$24,000
-77.4%
64,488
+493.8%
0.00%
Q4 2015$106,00010,8610.00%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 4,668,763$43,278,00014.12%
Aisling Capital LLC 2,983,797$27,660,0003.62%
INVESTOR AB 3,510,189$32,539,0002.91%
Foresite Capital Management II, LLC 459,266$4,257,0002.52%
RA Capital Management 1,458,792$13,523,0001.34%
Sio Capital Management, LLC 203,732$1,889,0001.08%
ACUTA CAPITAL PARTNERS, LLC 80,959$750,0000.63%
Pinnacle Wealth Management Advisory Group, LLC 49,623$460,0000.41%
CAXTON CORP 26,736$248,0000.30%
Cormorant Asset Management, LP 182,053$1,688,0000.26%
View complete list of AGILE THERAPEUTICS INC shareholders